Savara Inc Deferred Tax Liabilities, Intangible Assets
Savara Inc (SVRA) had Deferred Tax Liabilities, Intangible Assets of $2.14 million as of 2019-12-31, per its 10-K filed 2021-03-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2021-03-10
- 2019-12-31: Deferred Tax Liabilities, Intangible Assets $2.14M.
- 2018-12-31: Deferred Tax Liabilities, Intangible Assets $2.85M.
- 2017-12-31: Deferred Tax Liabilities, Intangible Assets $7.18M.
- 2016-12-31: Deferred Tax Liabilities, Intangible Assets $2.31M; Deferred Tax Liabilities, Intangible Assets as first filed $995.00K.
| Period end | Deferred Tax Liabilities, Intangible Assets | Deferred Tax Liabilities, Intangible Assets as first filed |
|---|---|---|
| 2019-12-31 | $2.14M 10-K · filed 2021-03-10 | |
| 2018-12-31 | $2.85M 10-K · filed 2020-03-12 | |
| 2017-12-31 | $7.18M 10-K · filed 2019-03-13 | |
| 2016-12-31 | $2.31M 10-K · filed 2018-03-14 | $995.00K 10-K · filed 2017-03-06 |
| 2015-12-31 | $3.40M 10-K · filed 2017-03-06 | |
| 2014-12-31 | $3.40M 10-K · filed 2016-03-14 | |
| 2013-12-31 | $2.61M 10-K · filed 2015-03-24 | $2.61M 10-K · filed 2014-03-26 |
| 2012-12-31 | $2.61M 10-K · filed 2014-03-26 | |
| 2011-12-31 | $2.61M 10-K · filed 2013-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |